MRI 市場 - 全球產業規模、佔有率、趨勢、機會和預測，按場強、類型、架構、應用、最終用戶、地區和競爭細分，2019-2029F

2023 年全球MRI 市場估值為52.5 億美元，預計在預測期內將穩定成長，到2029 年複合年成長率為5.25%。使精確的診斷成像徹底改變了醫學診斷和研究。多年來，在技術進步、慢性病盛行率不斷上升的推動下，全球MRI 市場經歷了顯著成長，而MRI 技術的興起也發生了巨大的發展，影像品質得到了改善，掃描時間變得更快，患者舒適度也提高了。用於研究大腦活動的高場 MRI、開放式 MRI 系統和功能性 MRI (fMRI) 等創新擴大了 MRI 的範圍和應用。

心血管疾病、癌症和神經系統疾病等慢性疾病需要準確、早期的診斷，以製定有效的治療計劃。 MRI 能夠提供軟組織、器官和血管的詳細影像，這使得它在這些疾病的診斷和治療中不可或缺。 MRI 的非侵入性，不暴露於電離輻射，使其成為患者和醫療保健提供者的首選。這推動了對 MRI 程序的需求超過 CT 掃描和 X 光等傳統影像方式。隨著全球人口老化，關節炎、失智症和中風等與年齡相關的疾病的盛行率有所上升。 MRI 在檢測解剖學和病理學細微變化方面的敏感性使其在老年護理中得到越來越多的採用。更高的醫療保健支出，尤其是在已開發地區，促進了更多人獲得核磁共振系統等先進醫療技術。新興經濟體也正在投資醫療基礎設施，進一步推動市場成長。

主要市場促進因素

慢性病盛行率的不斷上升正在推動全球 MRI 市場的發展

研究和臨床試驗中的新興應用正在推動全球 MRI 市場

主要市場挑戰

MRI 系統成本高

維護和營運費用

主要市場趨勢

技術進步

細分市場洞察

場強洞察

應用洞察

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：COVID-19 對全球 MRI 市場的影響

第 4 章：執行摘要

第 5 章：客戶之聲

第 6 章：全球 MRI 市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按場強（高場 MRI 系統（1.5t MRI 系統、3t MRI 系統）、中低場 MRI 系統（<1.5t）、甚高場 MRI 系統（4t 及以上））
  • 按類型（固定、移動）
  • 依架構（封閉式 MRI 系統和開放式 MRI 系統）
  • 按應用（腦和神經、腫瘤、脊椎和肌肉骨骼、腹部、心臟、其他）
  • 按最終使用者（醫院、影像中心、門診手術中心等）
  • 按公司分類 (2023)
  • 按地區
• 產品市場地圖

第 7 章：亞太地區 MRI 市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按場強
  • 按類型
  • 依架構
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 8 章：歐洲 MRI 市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按場強
  • 按類型
  • 依架構
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第 9 章：北美 MRI 市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按場強
  • 按類型
  • 依架構
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第 10 章：南美洲 MRI 市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按場強
  • 按類型
  • 依架構
  • 按申請
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第 11 章：中東和非洲 MRI 市場展望

• 市場規模預測
  • 按價值量
• 市佔率預測
  • 按場強
  • 按類型
  • 依架構
  • 按申請
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 12 章：市場動態

• 促進要素
• 挑戰

第 13 章：市場趨勢發展

• 併購（如有）
• 產品發布（如有）
• 最近的發展

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• GE Healthcare Technologies, Inc.
• Aurora Imaging Technologies, Inc.
• Sanrad Medical Systems Pvt ltd.
• Aspect Imaging
• Esaote SpA
• Fonar Corporation
• Hitachi Ltd
• Neusoft Medical Systems Co. Ltd
• Koninklijke Philips NV
• Siemens Healthcare GmbH
• Canon Medical Systems Corporation
• Mindray Medical International Limited
• Hologic, Inc.
• Nordion Inc.
• United Imaging Healthcare Co., Ltd

第 16 章：策略建議

第 17 章：關於我們免責聲明

Global MRI Marketwas valued at USD 5.25 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In the landscape of modern healthcare, Magnetic Resonance Imaging (MRI) stands as a cornerstone technology, enabling precise diagnostic imaging that has revolutionized medical diagnostics and research. The global MRI market has experienced significant growth over the years, driven by technological advancements, the increasing prevalence of chronic diseases, and the rise in MRI technology has evolved dramatically, with improvements in image quality, faster scanning times, and enhanced patient comfort. Innovations such as high-field MRI, open MRI systems, and functional MRI (fMRI) for studying brain activity have expanded the scope and applications of MRI.

Chronic diseases such as cardiovascular disorders, cancer, and neurological conditions require accurate and early diagnosis for effective treatment planning. MRI's ability to provide detailed images of soft tissues, organs, and blood vessels has made it indispensable in the diagnosis and management of these conditions. MRI's non-invasive nature, with no exposure to ionizing radiation, makes it a preferred choice for both patients and healthcare providers. This has driven demand for MRI procedures over traditional imaging modalities like CT scans and X-rays. As populations age worldwide, the prevalence of age-related conditions such as arthritis, dementia, and stroke has risen. MRI's sensitivity in detecting subtle changes in anatomy and pathology has contributed to its growing adoption in geriatric care. Higher healthcare spending, especially in developed regions, has facilitated greater access to advanced medical technologies like MRI systems. Emerging economies are also investing in healthcare infrastructure, further propelling market growth.

Key Market Drivers

Growing Prevalence of Chronic Diseases is Driving the Global MRI Market

The global healthcare landscape is witnessing a profound shift driven by the rising incidence of chronic diseases worldwide. This epidemiological trend has significantly contributed to the increased demand for advanced diagnostic imaging technologies, particularly Magnetic Resonance Imaging (MRI). MRI plays a pivotal role in the early detection, accurate diagnosis, and effective management of various chronic conditions, thereby driving the expansion of the global MRI market. Chronic diseases, characterized by their prolonged duration and generally slow progression, are now the leading cause of morbidity and mortality globally. Conditions such as cardiovascular diseases, cancer, diabetes, chronic respiratory diseases, and neurological disorders are becoming more prevalent, primarily due to aging populations, unhealthy lifestyles, and environmental factors. The burden of chronic illnesses is particularly pronounced in low- and middle-income countries, where healthcare systems often struggle to cope with the growing demand for diagnosis and treatment.

MRI has emerged as a cornerstone of diagnostic imaging for a wide range of chronic diseases. Its non-invasive nature and ability to produce detailed, high-resolution images of soft tissues make it indispensable for clinicians in the assessment and monitoring of chronic conditions. MRI is crucial in oncology for detecting tumors, evaluating disease extent, staging cancers, and monitoring treatment response. Advanced MRI techniques like diffusion-weighted imaging (DWI) and magnetic resonance spectroscopy (MRS) aid in tumor characterization and guide therapeutic decisions. MRI is employed for assessing cardiac structure and function, detecting myocardial infarction, evaluating congenital heart abnormalities, and diagnosing conditions like heart failure and cardiomyopathies. MRI is the gold standard for imaging the brain and spinal cord, facilitating the diagnosis of stroke, multiple sclerosis, Alzheimer's disease, brain tumors, and other neurological conditions. MRI is used extensively in orthopedics to assess joint abnormalities, ligament and tendon injuries, spinal disorders, and sports-related injuries. MRI is valuable in diagnosing liver diseases, pancreatic disorders, pelvic abnormalities, and gastrointestinal conditions.

Emerging Applications in Research and Clinical Trials is Driving the Global MRI Market

The integration of MRI into research and clinical trials is revolutionizing how medical discoveries are made and therapies are developed. MRI's unique capabilities to visualize soft tissues, organs, and physiological processes in real-time have opened doors to a multitude of applications that were previously challenging or impossible to achieve with other imaging modalities. Functional MRI (fMRI) enables researchers to map brain activity by detecting changes in blood flow and oxygenation levels associated with neuronal activity. This technique is pivotal in understanding brain function, mapping neural pathways, and investigating neurological disorders such as Alzheimer's disease, Parkinson's disease, and epilepsy. The insights gained from fMRI studies are crucial for developing targeted treatments and interventions.

Diffusion MRI is instrumental in studying the microstructure of white matter fibers in the brain. It provides valuable information about tissue integrity, connectivity, and neuroplasticity. Researchers leverage diffusion MRI to study conditions like multiple sclerosis, stroke, and traumatic brain injury, leading to advancements in treatment strategies and rehabilitation protocols. MRI biomarkers, including quantitative measures derived from imaging data, play a pivotal role in disease monitoring and treatment response assessment. In clinical trials, MRI biomarkers serve as objective measures of therapeutic efficacy, aiding in the development and validation of new drugs and therapies across various disease areas such as oncology, cardiology, and rheumatology.

Recent advances in molecular imaging techniques have enabled the visualization of specific molecular targets using MRI contrast agents. Molecular MRI facilitates the non-invasive detection of biomarkers associated with disease processes, paving the way for personalized medicine and targeted therapies. This approach holds promise for improving patient stratification and optimizing treatment outcomes. MRI-guided interventions combine real-time imaging with minimally invasive procedures, enabling precise targeting of pathological tissues while minimizing damage to healthy surrounding structures. MRI-guided interventions are employed in cancer therapy, pain management, and neurosurgery, enhancing treatment accuracy and patient safety.

The integration of MRI into research and clinical trials is a key driver of growth in the global MRI market. Pharmaceutical companies, academic institutions, and healthcare providers are increasingly leveraging MRI to accelerate drug development, validate therapeutic targets, and refine treatment protocols. The demand for advanced MRI systems capable of supporting these emerging applications is fueling market expansion. Furthermore, regulatory agencies are recognizing the value of MRI-derived data in decision-making processes, encouraging greater adoption of MRI technologies in clinical research. As MRI continues to evolve with cutting-edge innovations such as high-field strength magnets, functional imaging techniques, and artificial intelligence-driven analytics, its role in shaping the future of healthcare research and personalized medicine will only continue to grow.

Key Market Challenges

High Cost of MRI Systems

One of the primary challenges hindering the widespread adoption of MRI technology is the high upfront cost associated with MRI systems. The initial investment required to acquire and maintain MRI equipment is substantial, making it prohibitive for many healthcare facilities, especially in resource-constrained settings. The high cost of MRI systems can deter smaller hospitals and clinics from investing in this technology, limiting patient access to advanced imaging services.

Maintenance and Operational Expenses

In addition to the initial purchase cost, MRI systems require significant ongoing maintenance and operational expenses. Regular servicing, software updates, and replacement parts can add to the overall cost of ownership. Healthcare providers often face budgetary constraints when allocating resources for MRI maintenance, impacting the efficiency and uptime of MRI machines.

Key Market Trends

Technological Advancements

One of the most notable advancements in MRI technology is the development of high-field MRI systems, characterized by stronger magnetic fields (1.5 Tesla and above). High-field MRI machines offer superior image resolution, enabling radiologists to visualize fine anatomical details with greater clarity. This increased sensitivity is particularly beneficial for detecting subtle abnormalities, such as small tumors or microvascular changes, improving diagnostic accuracy and confidence. Modern MRI systems are equipped with advanced radiofrequency coil arrays that capture signals from the patient's body more efficiently. Multi-channel coil designs optimize signal reception, leading to enhanced image quality and faster scan times. These coil arrays can be tailored to specific imaging needs, facilitating imaging of various anatomical regions with optimal sensitivity and spatial coverage.

Gradient coils play a crucial role in spatially encoding MR signals and enabling rapid image acquisition. Recent advancements in gradient coil technology have led to the development of stronger and faster gradients, enabling accelerated imaging techniques such as echo planar imaging (EPI) and diffusion-weighted imaging (DWI). Improved gradient performance contributes to shorter scan times, reducing patient discomfort and increasing throughput in clinical settings. Parallel imaging techniques leverage multi-channel coil arrays to acquire multiple lines of k-space simultaneously, accelerating image acquisition without compromising spatial resolution. Additionally, advanced pulse sequences, such as turbo spin-echo (TSE) and fast spin-echo (FSE), allow for rapid data acquisition and reduced motion artifacts. These accelerated imaging methods enhance workflow efficiency and patient throughput, making MRI more accessible and convenient.

Technological advancements have expanded the clinical utility of MRI beyond anatomical imaging. Functional MRI (fMRI) techniques visualize changes in blood flow and oxygenation levels in response to neural activity, enabling mapping of brain function. MR spectroscopy measures metabolite concentrations within tissues, providing insights into biochemical processes. These functional imaging modalities have revolutionized neuroscience and neurosurgical planning, enhancing our understanding of brain disorders. Software innovations and AI-driven algorithms are transforming MRI data analysis and interpretation. AI technologies enable automated image reconstruction, motion correction, and quantitative analysis, streamlining workflows and reducing the burden on radiologists. AI-based image processing techniques enhance diagnostic accuracy and enable personalized medicine approaches tailored to individual patient characteristics. Technological advancements in MRI have prioritized patient comfort and safety. Innovations such as wide-bore MRI systems and noise reduction techniques mitigate claustrophobia and acoustic discomfort during scans. Moreover, real-time motion tracking and adaptive imaging strategies minimize motion artifacts, ensuring high-quality diagnostic results even in challenging patient populations. Emerging MRI applications, including cardiac MRI, musculoskeletal imaging, and molecular imaging, are expanding clinical indications and driving market growth. Tailored MRI sequences and contrast agents enable precise characterization of tissue properties, facilitating early disease detection and treatment monitoring across various medical specialties.

Segmental Insights

Field Strength Insights

Basedon the category of Field Strength, High-Field MRI Systems emerged as the dominant segment in the global market for MRI in 2023.High-Field MRI systems typically operate at field strengths of 1.5 Tesla (T) and above, offering superior imaging resolution compared to lower-field systems. Higher field strengths enable better visualization of anatomical structures and pathological changes, making them ideal for detailed diagnostic imaging across various medical specialties. The increased signal-to-noise ratio (SNR) in High-Field MRI systems translates into higher diagnostic accuracy. This is particularly important for detecting subtle abnormalities, characterizing soft tissue lesions, and accurately staging diseases. Radiologists and clinicians rely on high-quality images produced by High-Field MRI for confident diagnosis and treatment planning. High-Field MRI systems support a broad spectrum of clinical applications, including neuroimaging, musculoskeletal imaging, cardiovascular imaging, and oncology. The exceptional imaging capabilities of High-Field MRI facilitate advanced techniques such as diffusion-weighted imaging (DWI), functional MRI (fMRI), and magnetic resonance angiography (MRA), enabling comprehensive evaluation of complex medical conditions. With increasing prevalence of chronic diseases and complex medical cases, there is a growing demand for advanced imaging technologies that can provide detailed anatomical and functional information. High-Field MRI meets this demand by offering sophisticated imaging capabilities that aid in early detection, accurate diagnosis, and personalized treatment planning. High-Field MRI systems are favored by research institutions and academic centers for conducting cutting-edge studies in neuroscience, cognitive imaging, and other specialized fields. The high resolution and sensitivity of these systems enable researchers to explore brain function, study disease mechanisms, and develop novel imaging techniques. Continuous advancements in High-Field MRI technology have expanded its clinical utility and improved user experience. Innovations such as parallel imaging, advanced coil designs, and optimized imaging sequences have enhanced the efficiency and diagnostic performance of High-Field MRI systems, further driving their adoption in clinical practice. Major MRI manufacturers have invested heavily in developing High-Field MRI systems, leveraging research and development efforts to push the boundaries of imaging technology. This competitive landscape has led to the introduction of increasingly advanced and versatile High-Field MRI systems, strengthening their position as the preferred choice in the market.

Application Insights

The Brain and Neurological segment is projected to experience rapid growth during the forecast period. Brain and neurological disorders, such as stroke, Alzheimer's disease, multiple sclerosis, brain tumors, and epilepsy, represent a significant global health burden. The prevalence of these conditions is increasing due to aging populations and lifestyle factors, leading to a growing demand for advanced imaging techniques like MRI for accurate diagnosis and monitoring. MRI's superior soft tissue contrast and multiplanar imaging capabilities make it particularly effective for assessing brain anatomy and detecting abnormalities. MRI can visualize intricate structures within the brain, such as white matter, gray matter, blood vessels, and the spinal cord, providing detailed information without exposing patients to ionizing radiation. Neurological conditions often require precise diagnosis and treatment planning. MRI enables clinicians to identify subtle changes in brain structure and function, aiding in early detection, differential diagnosis, and personalized treatment strategies. This capability is crucial for optimizing patient outcomes and improving quality of life. Functional MRI (fMRI) techniques have revolutionized the study of brain function by mapping neuronal activity and connectivity in real-time. fMRI is instrumental in research and clinical settings for understanding brain physiology, cognitive processes, and neurological disorders. The integration of fMRI with traditional structural MRI enhances diagnostic capabilities and therapeutic interventions. The neuroscience field is witnessing a surge in research initiatives and clinical trials focused on understanding brain disorders and developing novel therapies. MRI plays a pivotal role in neuroimaging studies, providing valuable insights into disease mechanisms, treatment response, and biomarker discovery. This increased research activity drives the demand for MRI systems specialized for neurological applications.

Regional Insights

Asia Pacific emerged as the dominant region in the global MRI market in 2023, holding the largest market share in terms of value. Asia Pacific has witnessed substantial investments in healthcare infrastructure over the past decade. Rapid economic development in countries like China, India, and Southeast Asian nations has led to increased spending on healthcare facilities and equipment. This expansion has facilitated the establishment of modern hospitals and diagnostic centers equipped with advanced imaging technologies, including MRI systems. The region is experiencing a notable increase in the burden of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions. MRI plays a critical role in the diagnosis, treatment planning, and monitoring of these diseases. As the incidence of chronic illnesses rises, there is a growing demand for advanced imaging services, driving the adoption of MRI technology across Asia Pacific. Improved healthcare awareness among the population, coupled with rising disposable incomes, has led to greater demand for high-quality medical services in Asia Pacific. Patients and healthcare providers increasingly prefer advanced diagnostic technologies like MRI for accurate and non-invasive diagnosis. This demand has spurred the expansion of MRI services in urban centers and tertiary healthcare facilities. Asia Pacific has embraced technological advancements in healthcare, including MRI technology. The region has become a hub for manufacturing and innovation in medical devices, leading to the availability of advanced MRI systems tailored to local needs. Continuous improvements in MRI technology, such as higher field strengths, faster scan times, and enhanced imaging capabilities, have accelerated the adoption of MRI across the region. Governments in Asia Pacific have prioritized healthcare infrastructure development and investment in medical technology. Policies aimed at improving healthcare access, enhancing diagnostic capabilities, and reducing disease burden have encouraged the adoption of MRI technology. Subsidies, grants, and incentives for healthcare providers to procure MRI equipment have further fueled market growth.

Key Market Players

GE HealthcareTechnologies, Inc.

Aurora Imaging Technologies, Inc.

Sanrad Medical Systems Pvt ltd.

Aspect Imaging

Esaote SpA

Fonar Corporation

Hitachi Ltd

Neusoft Medical Systems Co. Ltd

Koninklijke Philips NV

Siemens Healthcare GmbH

Canon Medical Systems Corporation

Mindray Medical International Limited

Hologic, Inc.

Nordion Inc.

United Imaging Healthcare Co., Ltd

Report Scope:

In this report, Global MRI Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

MRI Market, By Field Strength:

High-Field MRI Systems

Low-To-Mid-Field MRI Systems

Very-High-Field MRI Systems

MRI Market, By Type:

Fixed

Mobile

MRI Market, By Architecture:

Closed MRI Systems

Open MRI Systems

MRI Market, By Application:

Brain and Neurological

Oncology

Spine and Musculoskeletal

Abdominal

Cardiac

Others

MRI Market, By End User:

Hospitals

Imaging Centers

Ambulatory Surgical Centers

Others

MRI Market, By Region:

Asia Pacific

China

India

Japan

South Korea

Australia

Europe

France

Germany

United Kingdom

Italy

Spain

North America

United States

Mexico

Canada

South America

Brazil

Argentina

Colombia

Middle East and Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the MRI Market.

Available Customizations:

Global MRI marketreport with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1.Product Overview

• 1.1.Market Definition
• 1.2.Scope of the Market
  • 1.2.1.Markets Covered
  • 1.2.2.Years Considered for Study
  • 1.2.3.Key Market Segmentations

2.Research Methodology

• 2.1.Objective of the Study
• 2.2.Baseline Methodology
• 2.3.Key Industry Partners
• 2.4.Major Association and Secondary Sources
• 2.5.Forecasting Methodology
• 2.6.Data Triangulation Validation
• 2.7.Assumptions and Limitations

3.Impact of COVID-19 on Global MRI Market

4.Executive Summary

• 4.1.Overview of the Market
• 4.2.Overview of Key Market Segmentations
• 4.3.Overview of Key Market Players
• 4.4.Overview of Key Regions/Countries
• 4.5.Overview of Market Drivers, Challenges, and Trends

5. Voice of Customer

6.Global MRI Market Outlook

• 6.1.Market Size Forecast
  • 6.1.1.By Value Volume
• 6.2.Market Share Forecast
  • 6.2.1.By Field Strength (High-Field MRI Systems (1.5t MRI Systems, 3t MRI Systems), Low-To-Mid-Field MRI Systems (<1.5t), Very-High-Field MRI Systems (4t and Above))
  • 6.2.2.By Type (Fixed, Mobile)
  • 6.2.3.By Architecture (Closed MRI Systems and Open MRI Systems)
  • 6.2.4.By Application (Brain and Neurological, Oncology, Spine and Musculoskeletal, Abdominal, Cardiac, Others)
  • 6.2.5.By End User (Hospitals, Imaging Centers, Ambulatory Surgical Centers, Others)
  • 6.2.6.By Company (2023)
  • 6.2.7.By Region
• 6.3.Product Market Map

7.Asia-Pacific MRI Market Outlook

• 7.1.Market Size Forecast
  • 7.1.1.By Value Volume
• 7.2.Market Share Forecast
  • 7.2.1.By Field Strength
  • 7.2.2.By Type
  • 7.2.3.By Architecture
  • 7.2.4.By Application
  • 7.2.5.By End User
  • 7.2.6.By Country
• 7.3.Asia-Pacific: Country Analysis
  • 7.3.1.China MRI Market Outlook
    • 7.3.1.1.Market Size Forecast
      • 7.3.1.1.1.By Value
    • 7.3.1.2.Market Share Forecast
      • 7.3.1.2.1.By Field Strength
      • 7.3.1.2.2.By Type
      • 7.3.1.2.3.By Architecture
      • 7.3.1.2.4.By Application
      • 7.3.1.2.5.By End User
  • 7.3.2.India MRI Market Outlook
    • 7.3.2.1.Market Size Forecast
      • 7.3.2.1.1.By Value
    • 7.3.2.2.Market Share Forecast
      • 7.3.2.2.1.By Field Strength
      • 7.3.2.2.2.By Type
      • 7.3.2.2.3.By Architecture
      • 7.3.2.2.4.By Application
      • 7.3.2.2.5.By End User
  • 7.3.3.Japan MRI Market Outlook
    • 7.3.3.1.Market Size Forecast
      • 7.3.3.1.1.By Value
    • 7.3.3.2.Market Share Forecast
      • 7.3.3.2.1.By Field Strength
      • 7.3.3.2.2.By Type
      • 7.3.3.2.3.By Architecture
      • 7.3.3.2.4.By Application
      • 7.3.3.2.5.By End User
  • 7.3.4.South Korea MRI Market Outlook
    • 7.3.4.1.Market Size Forecast
      • 7.3.4.1.1.By Value
    • 7.3.4.2.Market Share Forecast
      • 7.3.4.2.1.By Field Strength
      • 7.3.4.2.2.By Type
      • 7.3.4.2.3.By Architecture
      • 7.3.4.2.4.By Application
      • 7.3.4.2.5.By End User
  • 7.3.5.Australia MRI Market Outlook
    • 7.3.5.1.Market Size Forecast
      • 7.3.5.1.1.By Value
    • 7.3.5.2.Market Share Forecast
      • 7.3.5.2.1.By Field Strength
      • 7.3.5.2.2.By Type
      • 7.3.5.2.3.By Architecture
      • 7.3.5.2.4.By Application
      • 7.3.5.2.5.By End User

8.Europe MRI Market Outlook

• 8.1.Market Size Forecast
  • 8.1.1.By Value Volume
• 8.2.Market Share Forecast
  • 8.2.1.By Field Strength
  • 8.2.2.By Type
  • 8.2.3.By Architecture
  • 8.2.4.By Application
  • 8.2.5.By End User
  • 8.2.6.By Country
• 8.3.Europe: Country Analysis
  • 8.3.1.France MRI Market Outlook
    • 8.3.1.1.Market Size Forecast
      • 8.3.1.1.1.By Value
    • 8.3.1.2.Market Share Forecast
      • 8.3.1.2.1.By Field Strength
      • 8.3.1.2.2.By Type
      • 8.3.1.2.3.By Architecture
      • 8.3.1.2.4.By Application
      • 8.3.1.2.5.By End User
  • 8.3.2.Germany MRI Market Outlook
    • 8.3.2.1.Market Size Forecast
      • 8.3.2.1.1.By Value
    • 8.3.2.2.Market Share Forecast
      • 8.3.2.2.1.By Field Strength
      • 8.3.2.2.2.By Type
      • 8.3.2.2.3.By Architecture
      • 8.3.2.2.4.By Application
      • 8.3.2.2.5.By End User
  • 8.3.3.United Kingdom MRI Market Outlook
    • 8.3.3.1.Market Size Forecast
      • 8.3.3.1.1.By Value
    • 8.3.3.2.Market Share Forecast
      • 8.3.3.2.1.By Field Strength
      • 8.3.3.2.2.By Type
      • 8.3.3.2.3.By Architecture
      • 8.3.3.2.4.By Application
      • 8.3.3.2.5.By End User
  • 8.3.4.Italy MRI Market Outlook
    • 8.3.4.1.Market Size Forecast
      • 8.3.4.1.1.By Value
    • 8.3.4.2.Market Share Forecast
      • 8.3.4.2.1.By Field Strength
      • 8.3.4.2.2.By Type
      • 8.3.4.2.3.By Architecture
      • 8.3.4.2.4.By Application
      • 8.3.4.2.5.By End User
  • 8.3.5.Spain MRI Market Outlook
    • 8.3.5.1.Market Size Forecast
      • 8.3.5.1.1.By Value
    • 8.3.5.2.Market Share Forecast
      • 8.3.5.2.1.By Field Strength
      • 8.3.5.2.2.By Type
      • 8.3.5.2.3.By Architecture
      • 8.3.5.2.4.By Application
      • 8.3.5.2.5.By End User

9.North America MRI Market Outlook

• 9.1.Market Size Forecast
  • 9.1.1.By Value Volume
• 9.2.Market Share Forecast
  • 9.2.1.By Field Strength
  • 9.2.2.By Type
  • 9.2.3.By Architecture
  • 9.2.4.By Application
  • 9.2.5.By End User
  • 9.2.6.By Country
• 9.3.North America: Country Analysis
  • 9.3.1.United States MRI Market Outlook
    • 9.3.1.1.Market Size Forecast
      • 9.3.1.1.1.By Value
    • 9.3.1.2.Market Share Forecast
      • 9.3.1.2.1.By Field Strength
      • 9.3.1.2.2.By Type
      • 9.3.1.2.3.By Architecture
      • 9.3.1.2.4.By Application
      • 9.3.1.2.5.By End User
  • 9.3.2.Mexico MRI Market Outlook
    • 9.3.2.1.Market Size Forecast
      • 9.3.2.1.1.By Value
    • 9.3.2.2.Market Share Forecast
      • 9.3.2.2.1.By Field Strength
      • 9.3.2.2.2.By Type
      • 9.3.2.2.3.By Architecture
      • 9.3.2.2.4.By Application
      • 9.3.2.2.5.By End User
  • 9.3.3.Canada MRI Market Outlook
    • 9.3.3.1.Market Size Forecast
      • 9.3.3.1.1.By Value
    • 9.3.3.2.Market Share Forecast
      • 9.3.3.2.1.By Field Strength
      • 9.3.3.2.2.By Type
      • 9.3.3.2.3.By Architecture
      • 9.3.3.2.4.By Application
      • 9.3.3.2.5.By End User

10.South America MRI Market Outlook

• 10.1.Market Size Forecast
  • 10.1.1.By Value Volume
• 10.2.Market Share Forecast
  • 10.2.1.By Field Strength
  • 10.2.2.By Type
  • 10.2.3.By Architecture
  • 10.2.4.By Application
  • 10.2.5.By End User
  • 10.2.6.By Country
• 10.3.South America: Country Analysis
  • 10.3.1.Brazil MRI Market Outlook
    • 10.3.1.1.Market Size Forecast
      • 10.3.1.1.1.By Value
    • 10.3.1.2.Market Share Forecast
      • 10.3.1.2.1.By Field Strength
      • 10.3.1.2.2.By Type
      • 10.3.1.2.3.By Architecture
      • 10.3.1.2.4.By Application
      • 10.3.1.2.5.By End User
  • 10.3.2.Argentina MRI Market Outlook
    • 10.3.2.1.Market Size Forecast
      • 10.3.2.1.1.By Value
    • 10.3.2.2.Market Share Forecast
      • 10.3.2.2.1.By Field Strength
      • 10.3.2.2.2.By Type
      • 10.3.2.2.3.By Architecture
      • 10.3.2.2.4.By Application
      • 10.3.2.2.5.By End User
  • 10.3.3.Colombia MRI Market Outlook
    • 10.3.3.1.Market Size Forecast
      • 10.3.3.1.1.By Value
    • 10.3.3.2.Market Share Forecast
      • 10.3.3.2.1.By Field Strength
      • 10.3.3.2.2.By Type
      • 10.3.3.2.3.By Architecture
      • 10.3.3.2.4.By Application
      • 10.3.3.2.5.By End User

11.Middle East and Africa MRI Market Outlook

• 11.1.Market Size Forecast
  • 11.1.1.By Value Volume
• 11.2.Market Share Forecast
  • 11.2.1.By Field Strength
  • 11.2.2.By Type
  • 11.2.3.By Architecture
  • 11.2.4.By Application
  • 11.2.5.By End User
  • 11.2.6.By Country
• 11.3.MEA: Country Analysis
  • 11.3.1.South Africa MRI Market Outlook
    • 11.3.1.1.Market Size Forecast
      • 11.3.1.1.1.By Value
    • 11.3.1.2.Market Share Forecast
      • 11.3.1.2.1.By Field Strength
      • 11.3.1.2.2.By Type
      • 11.3.1.2.3.By Architecture
      • 11.3.1.2.4.By Application
      • 11.3.1.2.5.By End User
  • 11.3.2.Saudi Arabia MRI Market Outlook
    • 11.3.2.1.Market Size Forecast
      • 11.3.2.1.1.By Value
    • 11.3.2.2.Market Share Forecast
      • 11.3.2.2.1.By Field Strength
      • 11.3.2.2.2.By Type
      • 11.3.2.2.3.By Architecture
      • 11.3.2.2.4.By Application
      • 11.3.2.2.5.By End User
  • 11.3.3.UAE MRI Market Outlook
    • 11.3.3.1.Market Size Forecast
      • 11.3.3.1.1.By Value
    • 11.3.3.2.Market Share Forecast
      • 11.3.3.2.1.By Field Strength
      • 11.3.3.2.2.By Type
      • 11.3.3.2.3.By Architecture
      • 11.3.3.2.4.By Application
      • 11.3.3.2.5.By End User

12.Market Dynamics

• 12.1.Drivers
• 12.2.Challenges

13.Market Trends Developments

• 13.1.Merger Acquisition (If Any)
• 13.2.Product Launches (If Any)
• 13.3.Recent Developments

14.Porters Five Forces Analysis

• 14.1.Competition in the Industry
• 14.2.Potential of New Entrants
• 14.3.Power of Suppliers
• 14.4.Power of Customers
• 14.5.Threat of Substitute Products

15.Competitive Landscape

• 15.1.GE Healthcare Technologies, Inc.
  • 15.1.1.Business Overview
  • 15.1.2.Company Snapshot
  • 15.1.3.Products Services
  • 15.1.4.Financials (As Reported)
  • 15.1.5.Recent Developments
  • 15.1.6.Key Personnel Details
  • 15.1.7.SWOT Analysis
• 15.2.Aurora Imaging Technologies, Inc.
• 15.3.Sanrad Medical Systems Pvt ltd.
• 15.4.Aspect Imaging
• 15.5.Esaote SpA
• 15.6.Fonar Corporation
• 15.7.Hitachi Ltd
• 15.8.Neusoft Medical Systems Co. Ltd
• 15.9.Koninklijke Philips NV
• 15.10.Siemens Healthcare GmbH
• 15.11.Canon Medical Systems Corporation
• 15.12.Mindray Medical International Limited
• 15.13.Hologic, Inc.
• 15.14.Nordion Inc.
• 15.15.United Imaging Healthcare Co., Ltd

16.Strategic Recommendations

17. About Us Disclaimer